2 completed, 1 recruiting, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Unknown 1 |
Follow Treatment Outcome: new trials by email Literature Review of Treatment Outcome trials Research Report on Treatment Outcome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Edaravone Dexborneol Concentrated Solution for injection, Edaravone Dexborneol placebo - Ischemic Stroke, Acute, Treatment Outcome | Phase 3 | Unknown | Xiangya Hospital of Central South University | 212 | 2023-07-01 | 2023-06-27 |
| Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Tislelizumab in Combination with Bacillus Calmette-Guérin - Urinary Bladder Neoplasms, BCG Vaccine | Phase 3 | Recruiting | Fujian Medical University Union Hospital | 76 | 2023-06-01 | 2024-06-04 |
| Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions Mucopolysaccharide saline solution 0.9%, Saline solution 0.9% - Endoscopic Mucosal Resection, Colonic Neoplasms | Phase 3 | Completed | Nakafarma S.L. | 52 | 2021-01-18 | 2025-04-09 |
| Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction Vortioxetine, Escitalopram, Placebo - Treatment Outcome | Phase 3 | Completed | Takeda | 447 | 2011-06-01 | 2014-10-09 |
Colonic Neoplasms (1) · Depression (1) · Depressive Disorder, Major (1) · Ischemic Stroke (1) · Motor Activity (1) · Neoplasm Recurrence, Local (1) · Sexual Dysfunction, Physiological (1) · Urinary Bladder Neoplasms (1)
Behavior (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Behavioral Symptoms (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Depressive Disorder (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Female Urogenital Diseases (1)
Escitalopram (1) · Injections (1) · Saline Solution (1) · Vortioxetine (1) · tislelizumab (1)
Fujian Medical University Union Hospital (1) · Nakafarma S.L. (1) · Takeda (1) · Xiangya Hospital of Central South University (1)
China (2) · Canada (1) · Spain (1) · United States (1)
Jose Antonio Morales Molina, PhD in Pharmacy (1) · Zhang Le, PhD (1) · Zhenlin Chen (1)